chemical abortion

Woman holding white pill and a glass of water

Federal Judge Strikes Restrictions on Chemical Abortion Drug in N.C.

In an opinion filed April 30, U.S. District Court Judge Catherine Eagles struck down portions of North Carolina’s law restricting use of the chemical READ
Girl taking white pill and holding glass of water

Gov. Cooper and AG Stein Work to Prevent Restrictions on Chemical Abortion Drugs

In recent weeks Governor Roy Cooper and N.C. Attorney General Josh Stein have reasserted their pledge to make access to dangerous chemical abortion drugs READ
Girl taking white pill and holding glass of water

SCOTUS To Hear Oral Arguments on FDA’s Decisions on Dangerous Chemical Abortion Pills

This week, the Supreme Court of the United States (SCOTUS) announced that it will hear arguments this term about the Food and Drug Administration’s READ
Baby Being Held Ultrasound

No Longer a Destination State? The Initial Impact of NC’s New Pro-Life Law

Last week, the Guttmacher Institute released data revealing a 31% drop in abortions in North Carolina between June and July of this year, during READ
wooden judge's gavel

Judge Blocks Two Provisions of NC’s “Care for Women, Children, and Families Act”

On Saturday, September 30, a federal judge blocked two provisions of North Carolina’s new pro-life bill, SB 20—Care for Women, Children and Families Act. READ
Girl taking white pill and holding glass of water

Fifth Circuit Rules Chemical Abortion Drug Safeguards Must Be Restored by FDA

According to a report from our allies at Alliance Defending Freedom (ADF), “In a victory for women’s health, a unanimous panel for the U.S. READ
woman sitting on bed holding three white round pills

Lawsuit Challenges Legality of Chemical Abortion Drugs

Attorneys general of 23 states have filed two amicus briefs in support of a lawsuit seeking the withdrawal of FDA approval of the drugs READ
Walgreens pharmacy sign partially hidden by branch

FDA Approves Unsupervised Chemical Abortions

The United States Food and Drug Administration (FDA) announced earlier this week that it is removing its requirement for mifepristone to be administered in READ

Receive Our Legislative Alerts